2013
DOI: 10.3389/fonc.2013.00255
|View full text |Cite
|
Sign up to set email alerts
|

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma

Abstract: Changes in DNA methylation frequently accompany cancer development. One prominent change is an apparently genome-wide decrease in methylcytosine that is often ascribed to DNA hypomethylation at retroelements comprising nearly half the genome. DNA hypomethylation may allow reactivation of retroelements, enabling retrotransposition, and causing gene expression disturbances favoring tumor development. However, neither the extent of hypomethylation nor of retroelement reactivation are precisely known. We therefore… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
50
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 46 publications
(55 citation statements)
references
References 63 publications
4
50
0
1
Order By: Relevance
“…The most frequent tumor type in study was colorectal cancer analyzed in eight studies [15] , [21] , [28] [33] , followed by seven studies that evaluated methylation level in gastric cancer [23] , [27] , [32] , [34] [37] , five in hepatocellular carcinoma [25] , [38] [41] , four in bladder cancer [1] , [14] , [42] , [43] and head and neck carcinoma [10] , [44] – [46] , two in lung cancer [47] , [48] and breast cancer [24] , [49] , and single studies assessed methylation levels in renal cell cancer [50] , prostate cancer [51] , neuroendocrine tumor [52] , ovarian cancer [53] , thyroid cancer [54] , esophageal cancer [26] , cervix cancer [55] , endometrial cancer [32] , skin melanoma [22] , testicular cancer [56] , leukemia [57] , multiple myeloma [58] , paraganglioma [59] , fibrolamellar carcinoma [60] and gastrointestinal [61] . Four studies evaluated methylation level in several cancer sites [13] , [28] , [29] , [32] .…”
Section: Resultsmentioning
confidence: 99%
“…The most frequent tumor type in study was colorectal cancer analyzed in eight studies [15] , [21] , [28] [33] , followed by seven studies that evaluated methylation level in gastric cancer [23] , [27] , [32] , [34] [37] , five in hepatocellular carcinoma [25] , [38] [41] , four in bladder cancer [1] , [14] , [42] , [43] and head and neck carcinoma [10] , [44] – [46] , two in lung cancer [47] , [48] and breast cancer [24] , [49] , and single studies assessed methylation levels in renal cell cancer [50] , prostate cancer [51] , neuroendocrine tumor [52] , ovarian cancer [53] , thyroid cancer [54] , esophageal cancer [26] , cervix cancer [55] , endometrial cancer [32] , skin melanoma [22] , testicular cancer [56] , leukemia [57] , multiple myeloma [58] , paraganglioma [59] , fibrolamellar carcinoma [60] and gastrointestinal [61] . Four studies evaluated methylation level in several cancer sites [13] , [28] , [29] , [32] .…”
Section: Resultsmentioning
confidence: 99%
“…Hypomethylation of LINE-1 is associated with an increased risk for bladder cancer development. 9,22 We recently found that LINE-1 hypomethylation is associated with increased oxidative stress in both bladder cancer patients and healthy controls. 9 Moreover, we demonstrated that ROS was an inducing factor for LINE-1 hypomethylation in the bladder cancer cell line.…”
Section: Discussionmentioning
confidence: 99%
“…Global DNA hypomethylation, a genome-wide decrease in methylcytosine, occurs concomitantly, affecting in particular endogenous retroviruses (HERVs) and retrotransposons (SINEs and LINEs) and may result in their transcriptional reactivation 12 . In particular, substantial global LINE-1 DNA hypomethylation in bladder cancer is accompanied by a shift toward expression of full-length LINE-1 elements 13 .…”
mentioning
confidence: 99%